1780 related articles for article (PubMed ID: 20647199)
21. Treatment of antineutrophil cytoplasmic antibody-associated vasculitis: update.
Santana AN; Woronik V; Halpern AS; Barbas CS
J Bras Pneumol; 2011; 37(6):809-16. PubMed ID: 22241040
[TBL] [Abstract][Full Text] [Related]
22. Treatment of severe renal disease in ANCA positive and negative small vessel vasculitis with rituximab.
Shah S; Hruskova Z; Segelmark M; Morgan MD; Hogan J; Lee SK; Dale J; Harper L; Tesar V; Jayne DR; Geetha D
Am J Nephrol; 2015; 41(4-5):296-301. PubMed ID: 26044574
[TBL] [Abstract][Full Text] [Related]
23. How best to manage relapse and remission in ANCA-associated vasculitis.
Puéchal X; Guillevin L
Expert Rev Clin Immunol; 2022 Nov; 18(11):1135-1143. PubMed ID: 36102147
[TBL] [Abstract][Full Text] [Related]
24. Rituximab as Induction Therapy in Eosinophilic Granulomatosis with Polyangiitis Refractory to Conventional Immunosuppressive Treatment: A 36-Month Follow-Up Analysis.
Thiel J; Troilo A; Salzer U; Schleyer T; Halmschlag K; Rizzi M; Frede N; Venhoff A; Voll RE; Venhoff N
J Allergy Clin Immunol Pract; 2017; 5(6):1556-1563. PubMed ID: 28916432
[TBL] [Abstract][Full Text] [Related]
25. Rationale of concomitant cyclophosphamide for remission-induction in patients with antineutrophil cytoplasmic antibody-associated vasculitis: A propensity score-matched analysis of two nationwide prospective cohort studies.
Watanabe H; Sada KE; Matsumoto Y; Harigai M; Amano K; Fujimoto S; Dobashi H; Yuzawa Y; Yamagata K; Muso E; Arimura Y; Makino H
Mod Rheumatol; 2021 Jan; 31(1):205-213. PubMed ID: 31859544
[TBL] [Abstract][Full Text] [Related]
26. Adjunction of rituximab to steroids and immunosuppressants for refractory/relapsing Wegener's granulomatosis: a study on 8 patients.
Brihaye B; Aouba A; Pagnoux C; Cohen P; Lacassin F; Guillevin L
Clin Exp Rheumatol; 2007; 25(1 Suppl 44):S23-7. PubMed ID: 17428359
[TBL] [Abstract][Full Text] [Related]
27. Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab.
Eriksson P
J Intern Med; 2005 Jun; 257(6):540-8. PubMed ID: 15910558
[TBL] [Abstract][Full Text] [Related]
28. Current therapy of granulomatosis with polyangiitis and microscopic polyangiitis: the role of rituximab.
Geetha D; Kallenberg C; Stone JH; Salama AD; Appel GB; Duna G; Brunetta P; Jayne D
J Nephrol; 2015 Feb; 28(1):17-27. PubMed ID: 25185728
[TBL] [Abstract][Full Text] [Related]
29. Effect of Reduced-Dose vs High-Dose Glucocorticoids Added to Rituximab on Remission Induction in ANCA-Associated Vasculitis: A Randomized Clinical Trial.
Furuta S; Nakagomi D; Kobayashi Y; Hiraguri M; Sugiyama T; Amano K; Umibe T; Kono H; Kurasawa K; Kita Y; Matsumura R; Kaneko Y; Ninagawa K; Hiromura K; Kagami SI; Inaba Y; Hanaoka H; Ikeda K; Nakajima H;
JAMA; 2021 Jun; 325(21):2178-2187. PubMed ID: 34061144
[TBL] [Abstract][Full Text] [Related]
30. Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis.
Keogh KA; Wylam ME; Stone JH; Specks U
Arthritis Rheum; 2005 Jan; 52(1):262-8. PubMed ID: 15641078
[TBL] [Abstract][Full Text] [Related]
31. Long-term Outcomes of Rituximab Therapy in Ocular Granulomatosis with Polyangiitis: Impact on Localized and Nonlocalized Disease.
Joshi L; Tanna A; McAdoo SP; Medjeral-Thomas N; Taylor SR; Sandhu G; Tarzi RM; Pusey CD; Lightman S
Ophthalmology; 2015 Jun; 122(6):1262-8. PubMed ID: 25745876
[TBL] [Abstract][Full Text] [Related]
32. Rituximab therapy for Wegener's granulomatosis refractory to conventional treatment.
Sánchez-Escuredo A; Núñez R; Ibernón M; Martínez E; López D; Navarro M; Bonet J; Ara J; Romero R
Nefrologia; 2011; 31(4):502-4. PubMed ID: 21738261
[No Abstract] [Full Text] [Related]
33. Reducing glucocorticoid duration in ANCA-associated vasculitis: A pilot trial.
Miloslavsky EM; Niles JL; Wallace ZS; Cortazar FB; Fernandes A; Laliberte K; Stone JH
Semin Arthritis Rheum; 2018 Oct; 48(2):288-292. PubMed ID: 29530330
[TBL] [Abstract][Full Text] [Related]
34. Treatment of Granulomatosis with Polyangiitis and Microscopic Polyangiitis: Should Type of ANCA Guide the Treatment?
Tesar V; Hruskova Z
Clin J Am Soc Nephrol; 2020 Oct; 15(10):1519-1521. PubMed ID: 32471814
[No Abstract] [Full Text] [Related]
35. Long-term efficacy of remission-maintenance regimens for ANCA-associated vasculitides.
Terrier B; Pagnoux C; Perrodeau É; Karras A; Khouatra C; Aumaître O; Cohen P; Decaux O; Desmurs-Clavel H; Maurier F; Gobert P; Quémeneur T; Blanchard-Delaunay C; Bonnotte B; Carron PL; Daugas E; Ducret M; Godmer P; Hamidou M; Lidove O; Limal N; Puéchal X; Mouthon L; Ravaud P; Guillevin L;
Ann Rheum Dis; 2018 Aug; 77(8):1150-1156. PubMed ID: 29724729
[TBL] [Abstract][Full Text] [Related]
36. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis.
Guillevin L; Cordier JF; Lhote F; Cohen P; Jarrousse B; Royer I; Lesavre P; Jacquot C; Bindi P; Bielefeld P; Desson JF; Détrée F; Dubois A; Hachulla E; Hoen B; Jacomy D; Seigneuric C; Lauque D; Stern M; Longy-Boursier M
Arthritis Rheum; 1997 Dec; 40(12):2187-98. PubMed ID: 9416856
[TBL] [Abstract][Full Text] [Related]
37. A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis.
Jones RB; Ferraro AJ; Chaudhry AN; Brogan P; Salama AD; Smith KG; Savage CO; Jayne DR
Arthritis Rheum; 2009 Jul; 60(7):2156-68. PubMed ID: 19565480
[TBL] [Abstract][Full Text] [Related]
38. Rituximab for induction and maintenance therapy in granulomatosis with polyangiitis (Wegener's). Results of a single-center cohort study on 66 patients.
Calich AL; Puéchal X; Pugnet G; London J; Terrier B; Charles P; Mouthon L; Guillevin L;
J Autoimmun; 2014 May; 50():135-41. PubMed ID: 24703438
[TBL] [Abstract][Full Text] [Related]
39. [Update on treatment of ANCA-associated vasculitis: Granulomatosis with polyangiitis and Microscopic Polyangiitis].
Holle JU; Hellmich B; Moosig F
Z Rheumatol; 2022 May; 81(4):280-285. PubMed ID: 35061059
[TBL] [Abstract][Full Text] [Related]
40. Combination treatment with rituximab, low-dose cyclophosphamide and plasma exchange for severe antineutrophil cytoplasmic antibody-associated vasculitis.
Gulati K; Edwards H; Prendecki M; Cairns TD; Condon M; Galliford J; Griffith M; Levy JB; Tam FWK; Tanna A; Pusey CD; McAdoo SP
Kidney Int; 2021 Dec; 100(6):1316-1324. PubMed ID: 34560140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
